Jordanian drugmaker Hikma Pharmaceuticals said it expected first-half revenue to grow around 40 per cent.

Hikma also said in a trading update, ahead of the release of results for the first half of 2007 on September 5, it was confident of delivering sales growth in excess of 35 per cent for the year.

'Hikma has performed well in the year to date,' chairman and chief executive Samih Darwazah said in the statement.

'We continue to show growth in our key businesses and I am confident that, on the back of very solid fundamentals, we are well-placed to deliver another year of strong growth, in line with our expectations,' he added. Reuters